DL-threo-Ritalinic acid

CAS: 54631-24-2

Ref. 3D-IR180350

Produktinformation

• Name: DL-threo-Ritalinic acid
• Marke: Biosynth
• Beschreibung: DL-threo-Ritalinic Acid is a dopamine receptor agonist that has been shown to be effective in treating hyperactivity, or attention deficit disorder (ADHD). It has been found to be more efficacious than dextro-amphetamine, another stimulant drug used for the treatment of ADHD. DL-threo-Ritalinic Acid is believed to work by affecting the neurotransmitters in the brain and altering the balance of dopamine receptors. In a two-way crossover study, preschool children were given either 0.5mg/kg of DL-threo-Ritalinic Acid or placebo for three days. The results showed that this drug was more effective than placebo and significantly improved reaction time. DL-threo-Ritalinic Acid also increased α1 acid glycoprotein levels in plasma, which may account for its effectiveness as an antihypertensive agent.

Chemische Eigenschaften

• Molekulargewicht: 219.28 g/mol
• Formel: C₁₃H₁₇NO₂
• Reinheit: Min. 95%